Yale Capital Corp. »

Vertex Pharmaceuticals Incorporated shares owned by Yale Capital Corp.

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Yale Capital Corp. from 13F filings

Historical chart of Yale Capital Corp. investment in Vertex Pharmaceuticals Incorporated

May 2024Jul 2024Sep 2024Nov 2024Jan 20251.7M1.8M1.9M410041504200
Value ($)Share countHistorical VRTX position of Yale Capital Corp. Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Yale Capital Corp. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Yale Capital Corp.

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.6M 4.1k 402.70
2024-09-30 $2.0M 4.2k 465.08
2024-03-31 $1.8M 4.2k 418.01

More positions owned by Yale Capital Corp.

Jabil Circuit (JBL)
Cintas Corporation (CTAS)
Enterprise Products Partners (EPD)
Apple (AAPL)
Home Depot (HD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Blackstone Group Inc Com Cl A (BX)
Energy Transfer Com Ut Ltd Ptn (ET)
Axon Enterprise (AXON)
Microsoft Corporation (MSFT)
Nike CL B (NKE)
Msci (MSCI)
NVIDIA Corporation (NVDA)

View all positions for Yale Capital Corp.

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
Capital Research Global Investors
FMR
Jpmorgan Chase & Co
Wellington Management Company
Geode Capital Management
Jennison Associates
Alliancebernstein
Loomis, Sayles and
Norges Bank Investment Management
Amundi
Morgan Stanley

View all funds holding Vertex Pharmaceuticals Incorporated